FDA
approval
· 2024-11-21
FDA Approved: BUTALBITAL, ASPIRIN, AND CAFFEINE — Supplemental Application (Lannett Company, Inc.)
Summary
The FDA approved a supplemental ANDA from Lannett Company to market a generic Butalbital, Aspirin, and Caffeine product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUTALBITAL, ASPIRIN, AND CAFFEINE (BUTALBITAL, ASPIRIN, AND CAFFEINE)